Lung Cancer, 3rd Edition Available Now

Business Wire, Feb 1, 2008

DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c81524) has announced the addition of "Lung Cancer, 3rd Edition" to their offering

Lung cancer is a major cause of cancer-related deaths in men and women. However, since the first edition of Lung Cancer was published 14 years ago, rapid progress in the biology, prevention, diagnosis, and treatment of the disease has been made.

Authors bio:

Jack A. Roth, MD FACS, Professor and Chairman, Bud Johnson Clinical Distinguished Chair, The University of Texas M.D. Anderson Cancer Center, Department of Thoracic & Cardiovascular Surgery and Professor of Molecular and Cellular Oncology, Director, W.M. Keck Center for Cancer Gene Therapy, Houston, Texas, USA.

James D. Cox, MD, Professor and Head, Division of Radiation Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.

Waun Ki Hong, MD, American Cancer Society Clinical Research Professor, Charles A. LeMistre Distinguished Chair in Thoracic Oncology and Professor and Chairman, Department of Thoracic/Head and Neck Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.

Topics Covered:

-Smoking Cessation

- Lung Cancer Susceptibility Genes

- Lung Cancer Susceptibility and Risk Assessment Models

- The Molecular Genetics of Lung Cancer

- Molecular Biology of Preneoplastic Lesions of the Lung

- Detection of Preneoplastic Lesions

- Treatment of Preneoplastic Lesions of the Lung

- The Pathology and Pathogenesis of Peripheral Lung Adenocarcinoma Including Bronchioloalveolar Carcinoma

- Treatment of Bronchioloalveolar Carcinoma

- Molecular Profiling for Early Detection and Prediction of Response in Lung Cancer

- The Role for Mediastinoscopy in the Staging of Nonsmall Cell Lung Cancer

- Minimally Invasive Surgery for Lung Cancer

- Extended Resections for Lung Cancer

- Adjuvant Chemotherapy Following Surgery for Lung Cancer

- Induction Chemotherapy for Resectable Lung Cancer

- Image-Guided Radiation Therapy

- Stereotactic Body Radiation Therapy for Lung Cancer

- Proton Therapy

- Combinations of Radiation Therapy and Chemotherapy for Nonsmall Cell Lung Carcinoma

- New Chemotherapeutic Agents in Lung Cancer

- Immunologic Approaches to Lung Cancer Therapy

- Epidermal Growth Factor Receptor Inhibitors

- Tumor Angiogenesis: Biology and Therapeutic Implications for Lung Cancer

-Retinoids and Rexinoids in Lung Cancer Prevention and Treatment

-Proteasome Inhibition in Nonsmall Cell Lung Cancer Therapy

-Targeted Genetic Therapy for Lung Cancer

-Screening for Early Detection

-Natural Agents for Chemoprevention of Lung Cancer

Index

For more information, visit http://www.researchandmarkets.com/reports/c81524